BI-RADS
description
Transcript of BI-RADS
![Page 1: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/1.jpg)
BI-RADS
By Nina Zahedi MD
![Page 2: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/2.jpg)
Why BI-RADS?
![Page 3: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/3.jpg)
![Page 4: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/4.jpg)
Confusion
![Page 5: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/5.jpg)
If I report she is really sick what happens if she is not?
If I report normal what happens if she is really sick?
![Page 6: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/6.jpg)
Consultation
![Page 7: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/7.jpg)
And now
Baby of 1997 !
![Page 8: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/8.jpg)
Breast Imaging Reporting and Data System (BI-RADS).
• Having a standard way of reporting mammogram results , meaning:
• Lets doctors use the same words and terms for describing the findings ,
• Reduce confusion in breast imaging interpretations,
• and Facilitate outcome monitoring.
![Page 9: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/9.jpg)
Overall assessment & Recommendation studies
Report organisationIndication
Breast compositionFindings
Comparison to previous study
![Page 10: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/10.jpg)
• If more than one imaging modality is performed,
an integrated report with assessment based on the
highest level of suspicion must be used.
![Page 11: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/11.jpg)
Mammographic Breast Composition
The breast is almost entirely fat(<25% FGT)
Scattered fibroglandular densities (25-50%)
Heterogeneously dense breast tissue(51-75%)
Extremely dense (> 75% glandular)
![Page 12: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/12.jpg)
![Page 13: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/13.jpg)
![Page 14: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/14.jpg)
BIRADS Lexicon
• Mass
• Architectural distortion
• Asymmetry
• Calcification
![Page 15: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/15.jpg)
BI-RADS 1
Negative:
There is nothing to comment on.
( either abnormal or normal)
![Page 16: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/16.jpg)
![Page 17: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/17.jpg)
BI-RADS 2 :Benign Lesion
![Page 18: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/18.jpg)
Benign Masses can be Ignored• a-Raised skin lesions
Seborrheic keratosis
• b-Intramammary lymph nodes
• c-Fat containing lesions(Encapsulated lucent lesions) Lipomas Fat necrosis forming oil cysts Galactoceles
• c-Mixed-density lesions Hamartomas, Hematomas
![Page 19: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/19.jpg)
• d-Multiple rounded densities
• e-Benign calcified masses Calcifying involuting fibroadenomas
• f-Benign masses with peripheral calcifications Calcifying involuting fibroadenomas Cysts with calcified walls Fat necrosis
• g-Calcifying large duct papillomas
• h-Cysts with precipitated calcium
![Page 20: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/20.jpg)
The verrucoid appearance is typical of the benign, cutaneous seborrheic keratosis that is projecting over the breast.
![Page 21: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/21.jpg)
Typical appearance of a benign, intramammary lymph node.
![Page 22: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/22.jpg)
Fatty-replaced intramammary node. Single intramammary lymph node contains so much fat that it appears to be multiple masses .
![Page 23: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/23.jpg)
![Page 24: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/24.jpg)
Lipoma: The palpable mass in the axillary tail is radiolucent with a thin capsule .
![Page 25: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/25.jpg)
Posttraumatic oil cyst: A palpable mass in an area of previous surgery. It represents encapsulated, radiolucent fat and is a form of benign fat necrosis . No need for further investigation.
![Page 26: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/26.jpg)
Calcified oil cyst :This calcified mass represents an area of fat necrosis. The non calcified portion is relatively radiolucent.
![Page 27: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/27.jpg)
These calcifications are in the wall of a cyst .This lesion requires no further evaluation.
![Page 28: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/28.jpg)
Hamartoma : This mixed lesion contains fat and fibroglandular tissue. Requires no further evaluation.
![Page 29: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/29.jpg)
![Page 30: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/30.jpg)
Cysts accounting for multiple rounded densities
![Page 31: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/31.jpg)
Multiple fibroadenomas can account for multiple rounded densities
![Page 32: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/32.jpg)
Normal breast tissue may project as multiple rounded densities not cysts!
![Page 33: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/33.jpg)
CALCIFICATIONS THAT CAN BE IGNORED• Lucent-centered calcifications
Skin calcificationsFat necrosisSecretory calcifications(Large rod-shaped calcifications)
• Milk of calcium
• Vascular calcifications
• Dystrophic calcifications
• Diffusely scattered calcifications (? bilateral)
• Foreign Body Reaction and Calcified Suture Material
• Artifacts and Skin Contaminants
![Page 34: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/34.jpg)
Skin calcifications
![Page 35: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/35.jpg)
Dystrophic and suture calcifications
![Page 36: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/36.jpg)
Diffusely scattered calcifications
![Page 37: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/37.jpg)
BI-RADS 3•
Probably Benign Finding - Initial Short-Interval Follow-Up Suggested:
A finding placed in this category should have less than a 2% risk of malignancy.
It is not expected to change over the follow-up interval, but the radiologist would prefer to establish its stability.
![Page 38: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/38.jpg)
• Solitary circumscribed mass
•Solitary asymmetric duct
•Round, regular clustered calcifications
![Page 39: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/39.jpg)
![Page 40: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/40.jpg)
Non-palpable sharply defined lesion with a cluster of punctate calcification
![Page 41: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/41.jpg)
• The initial short-term follow-up :
• A unilateral mammogram at 6 months,
• Then a bilateral follow-up examination at 12 months and 24 months after the initial examination.
If the findings shows no change in the follow up the final assessment is changed to
BI-RADS 2 (benign) and no further follow up is needed.
![Page 42: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/42.jpg)
Follow up at 6, 12 and 24 months showed no change. Final assessment was changed to a Category 2.
![Page 43: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/43.jpg)
• If a BI-RADS 3 lesion shows any change during follow up,
• It will change into a BI-RADS 4 or 5 and appropriate action should be taken.
![Page 44: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/44.jpg)
Category 3 lesion: There are two indeterminate or amorphous calcifications.
![Page 45: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/45.jpg)
Final diagnosis: Invasive carcinoma within an area of DCIS.
![Page 46: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/46.jpg)
• First control after conservative treatment for breast cancer:
• New scars and post irradiation thickening of skin and interestitium is assigned BI-RADS 3.
•second control after Conservative treatment for breast cancer: decrease of sequelae of treatment, BI-RADS category can be changed into BI-RADS 2.
![Page 47: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/47.jpg)
First and second control after conservative treatment for breast cancer (BI-RADS 3 and 2)
![Page 48: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/48.jpg)
BI-RADS 4
Suspicious Abnormality - Biopsy Should Be Considered:BI-RADS 4 is reserved for findings that do not have the classic appearance of malignancy but have a wide range of probability of malignancy (2 - 95%).
![Page 49: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/49.jpg)
• Lesions with Ill-Defined Margins.
• Lesions with a Microlobulated Margin.
• Architectural Distortion.
• Distorted Parenchymal Edge.
• Density Increasing Over Time.
• Focal Asymmetric Density.
• Clustered Microcalcifications.
![Page 50: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/50.jpg)
Category 4: There is an abnormality suspicious for malignancy, but a benign lesion.
![Page 51: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/51.jpg)
![Page 52: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/52.jpg)
BI-RADS 5
Highly Suggestive of Malignancy. Appropriate Action Should Be Taken:
classic breast cancers, with a >95% likelihood of malignancy. A spiculated, irregular high-density mass,
a segmental or linear arrangement of fine linear calcifications
or an irregular spiculated mass with associated pleomorphic calcification.
![Page 53: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/53.jpg)
![Page 54: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/54.jpg)
![Page 55: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/55.jpg)
•New oncologic management requires percutaneous tissue sampling is included in surgical treatment or when neoadjuvant chemotherapy is administered.
![Page 56: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/56.jpg)
BI-RADS 6•
Known Biopsy Proven Malignancy. Appropriate Action Should Be Taken lesions identified on the imaging study with biopsy proof of malignancy prior to definitive therapy.
•These patients are treated with neo-adjuvant chemotherapy. During the course of the treatment the tumor may be less visible, while still you know you are dealing with cancer.
![Page 57: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/57.jpg)
LEFT: initial mammogram with marker on palpable mass. Biopsy proven carcinoma.RIGHT: after chemotherapy. Tumor is hardly visible.
![Page 58: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/58.jpg)
Initial ultrasound shows large tumor.(3.6 cm) After chemotherapy shrinkage of the tumor. category 6: After treatment 1.8 cm.
![Page 59: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/59.jpg)
BI-RADS 0• Need Additional Imaging Evaluation and/or Prior
Mammograms For Comparison:
When additional imaging studies are completed, a final assessment is made.
Always try to avoid this category by immediately doing additional imaging or retrieving old films before reporting.
![Page 60: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/60.jpg)
BI-RADS 0 at screening:Additional ultrasound after referral was performed allowing final assessment.
![Page 61: BI-RADS](https://reader035.fdocuments.in/reader035/viewer/2022081520/568165e9550346895dd90b34/html5/thumbnails/61.jpg)